Literature DB >> 19050397

Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy.

Jan K Damås1, Linn Landrø, Børre Fevang, Lars Heggelund, Stig S Frøland, Pål Aukrust.   

Abstract

The CCR7 ligands, CCL19 and CCL21, coordinate lymph node homing of naive and central memory T cells. In untreated HIV-infected patients, serum levels of CCL19 and CCL21 showed a biphasic pattern during progression; a marked increase was followed by a decline in patients with advanced immunodeficiency. During highly active antiretroviral therapy, a decrease in CCL19/CCL21 levels was restricted to virologic responders. We suggest that dysregulation of CCR7 ligands may play an important role in progression of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19050397     DOI: 10.1097/QAD.0b013e32831cf595

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

Authors:  Paul U Cameron; Suha Saleh; Georgina Sallmann; Ajantha Solomon; Fiona Wightman; Vanessa A Evans; Genevieve Boucher; Elias K Haddad; Rafick-Pierre Sekaly; Andrew N Harman; Jenny L Anderson; Kate L Jones; Johnson Mak; Anthony L Cunningham; Anthony Jaworowski; Sharon R Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

2.  Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS).

Authors:  J K Damås; O Øktedalen; T Ueland; L Landrø; J Barstad; F Müller; S S Frøland; T H Flo; P Aukrust
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes.

Authors:  Joseph C Mudd; Patrick Murphy; Maura Manion; Robert Debernardo; Jeffrey Hardacre; John Ammori; Gareth A Hardy; Clifford V Harding; Ganapati H Mahabaleshwar; Mukesh K Jain; Jeffrey M Jacobson; Ari D Brooks; Sharon Lewis; Timothy W Schacker; Jodi Anderson; Elias K Haddad; Rafael A Cubas; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

Review 4.  Novel anti-HIV therapeutics targeting chemokine receptors and actin regulatory pathways.

Authors:  Mark Spear; Jia Guo; Yuntao Wu
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 5.  HIV persistence: chemokines and their signalling pathways.

Authors:  Vanessa A Evans; Gabriela Khoury; Suha Saleh; Paul U Cameron; Sharon R Lewin
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-28       Impact factor: 7.638

6.  Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.

Authors:  Jennifer M Zerbato; Erik Serrao; Gina Lenzi; Baek Kim; Zandrea Ambrose; Simon C Watkins; Alan N Engelman; Nicolas Sluis-Cremer
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  A divergent myeloid dendritic cell response at virus set-point predicts disease outcome in SIV-infected rhesus macaques.

Authors:  S M Barratt-Boyes; V Wijewardana
Journal:  J Med Primatol       Date:  2011-07-01       Impact factor: 0.667

8.  A dichotomy in cortical actin and chemotactic actin activity between human memory and naive T cells contributes to their differential susceptibility to HIV-1 infection.

Authors:  Weifeng Wang; Jia Guo; Dongyang Yu; Paul J Vorster; WanJun Chen; Yuntao Wu
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

9.  Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.

Authors:  J K Damås; L Landrø; B Fevang; L Heggelund; G E Tjønnfjord; Y Fløisand; B Halvorsen; S S Frøland; P Aukrust
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

10.  Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells.

Authors:  Jia Guo; Weifeng Wang; Dongyang Yu; Yuntao Wu
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.